CXCR4 and neoplasm: Indeed, individual inhibitors of CXCR4, CXCR7 (CCX2066, ChemoCentryx), and CXCR3 (AMG487) showed partial effectiveness in reducing tumour growth and metastasis [132] and they are still in preclinical studies.